ClinicalTrials.gov
ClinicalTrials.gov Menu

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005605
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : February 21, 2011
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Northwestern University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2005
  Actual Study Completion Date : October 2005